Target intelligence / Profile preview

Cyclic nucleotide-gated channel subunit beta-1 (CNGB1)

Target
CNGB1
Molecular classification
Ion channel, Pore-loop cation channel, Ligand-gated channel, Cyclic nucleotide-gated (CNG) channel family
01

Overview

Cyclic nucleotide-gated channel subunit beta-1 (CNGB1) is a critical pore-forming subunit of the rod photoreceptor CNG channel, which is activated by cyclic nucleotides (cAMP/cGMP) rather than changes in voltage. In the retina, CNGB1 combines with alpha subunits (primarily CNGA1) to form heterotetrameric channels key for phototransduction under low light conditions by regulating Na⁺ and Ca²⁺ influx. CNGB1 also contains a specialized N-terminal glutamic acid-rich protein (GARP) region crucial for channel targeting and structural integrity of rod outer segments. Pathogenic variants or loss of CNGB1 result in rod dysfunction, leading to retinitis pigmentosa and, in some cases, mild olfactory defects. Apart from rods, alternative splice forms participate in olfactory signaling. No direct pharmacological modulators are clinically used; gene-based therapies are being explored in experimental settings.

Other names
Cyclic nucleotide-gated channel beta-1CNGB1CNG channel beta-1CNG4Cyclic nucleotide-gated cation channel beta-1Cyclic nucleotide-gated cation channel 4GARP (Glutamic acid-rich protein)GAR1GARP2RCNC2RCNCbRP45Cyclic nucleotide-gated cation channel gammaCyclic nucleotide-gated channel modulatory subunitCNCG2CNCG3LCNCG4
02

Mechanism of action

For future therapies: Restoration of channel function by gene therapy, targeted repair of pathogenic mutations, or molecular modulation of channel gating. CNGB1's physiological mechanism involves ligand gating by cyclic nucleotides (cAMP, cGMP) causing channel opening and permitting cation influx

03

Biological functions

Visual phototransduction (in rods)Olfactory signal transduction (in olfactory neurons for splice variants)Ion transport (Na⁺, Ca²⁺) across the plasma membraneRegulation of membrane potentialProtein localization to organelle
04

Disease associations

Retinal degenerative diseases (especially retinitis pigmentosa type 45)RP-olfactory dysfunction syndrome (with variable anosmia/hyposmia)
05

Safety considerations

Because CNGB1 deficiency results in progressive retinal degeneration, therapeutic interventions must be carefully tailored to avoid off-target effects or immune reactionsGene therapy approaches may pose general risks (immune response, integration effects), but no specific CNGB1-targeting drugs are approved
06

Interacting drugs

No currently approved drugs directly target CNGB1 in clinical use; mutation and deficiency are primarily associated with disease, and therapies (such as gene therapy or small molecules for retinitis pigmentosa) are experimental
07

Biomarkers

CNGB1 mutations are used as a molecular diagnostic biomarker for retinitis pigmentosa type 45Possible use in disease monitoring by genotyping

Beyond the preview

Go deeper on Cyclic nucleotide-gated channel subunit beta-1 (CNGB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclic nucleotide-gated channel subunit beta-1 (CNGB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call